Biovica: Adding DiviTum market reach - Redeye

BIovica has entered a reference lab agreement with Tempus a US listed company. Biovica is a smaller company addressing a large market and it is very important to secure collaborations expanding its market reach and access to externa sales teams. Tempus allows access for DiviTum into a network of over 6,500 oncologists.

Länk till analysen i sin helhet: https://www.redeye.se/research/1107873/biovica-adding-divitum-market-reach?utm_source=finwire&utm_medium=RSS